Skip to main content

Great.gov.uk will be unavailable from Monday 3rd February 2025 at 5pm UK time whilst we carry out essential maintenance. You will be able to use the website from Tuesday 4th February 2025 at midday UK time.

  1. Home

Results found

Displaying items 1141 - 1150 of 1536 in total

  • Export opportunity Drugs

    Conclusion of non-exclusive discount contracts in accordance with §§ 130a Para. 8/130c Para. 1 SGB V for drugs with the active ingredient dronedarone (C01BD07)…

  • Export opportunity Drugs

    Conclusion of non-exclusive discount contracts in accordance with §§ 130a Para. 8/130c Para. 1 SGB V for drugs with the active ingredient aclidinium bromide (R…

  • Export opportunity Drugs

    Conclusion of non-exclusive discount contracts in accordance with §§ 130a Para. 8/130c Para. 1 SGB V for drugs with the active ingredient Follitropin beta (G03…

  • Export opportunity Drugs

    Conclusion of non-exclusive discount contracts in accordance with §§ 130a Para. 8/130c Para. 1 SGB V for drugs with the active ingredient olodaterol and tiotro…

  • Export opportunity Drugs

    Conclusion of non-exclusive discount contracts in accordance with §§ 130a Para. 8/130c Para. 1 SGB V for drugs with the active ingredient Flupentixol (N05AF01)…

  • Export opportunity Drugs

    Conclusion of non-exclusive discount contracts in accordance with §§ 130a Para. 8/130c Para. 1 SGB V for drugs with the active ingredient octreotide (H01CB02) …

  • Export opportunity Drugs

    Conclusion of non-exclusive discount contracts in accordance with §§ 130a Para. 8/130c Para. 1 SGB V for drugs with the active ingredient valproic acid (N03AG0…

  • Export opportunity Drugs

    Conclusion of non-exclusive discount contracts in accordance with §§ 130a Para. 8/130c Para. 1 SGB V for drugs with the active ingredient fulvestrant (L02BA03)…

  • Export opportunity Drugs

    Conclusion of non-exclusive discount contracts in accordance with §§ 130a Para. 8/130c Para. 1 SGB V for drugs with the active ingredient metoclopramide (A03FA…

  • Export opportunity Drugs

    Conclusion of non-exclusive discount contracts in accordance with §§ 130a Para. 8/130c Para. 1 SGB V for drugs with the active ingredient tamsulosin and dutast…

Something went wrong. Please try again.

Was this page useful?

Thanks for letting us know

Can you tell us why this page was useful?

Do not share any personal or commercially sensitive information.

Cancel

Thanks for letting us know

Can you tell us more about your feedback?

Do not share any personal or commercially sensitive information.

Cancel

Thanks for your feedback